Bone Regeneration with Dental Pulp Stem Cells in an Experimental Model
Haifa Hamad-Alrashid1, Sandra Muntión2,3, Fermín Sánchez-Guijo3,4,5
1Doctoral School "Studii Salamantini", University of Salamanca, 37008 Salamanca, Spain.
Journal of Personalized Medicine
|November 26, 2024
Summary
Mesenchymal stromal cells from dental pulp (DP-MSCs) combined with biomaterials significantly enhance bone regeneration in critical defects. This tissue bioengineering approach shows promising results for bone repair and therapeutic applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Oral and Maxillofacial Surgery
Background:
- Bone mass loss and limited self-regeneration necessitate advanced therapeutic strategies.
- Tissue bioengineering offers a potential alternative to conventional bone defect treatments.
- Investigating novel biomaterials and cell therapies is crucial for bone regeneration research.
Purpose of the Study:
- To evaluate bone regeneration in critical bone defects using Evolution® and Gen-Os® biomaterials.
- To assess the efficacy of combining these biomaterials with dental pulp-derived mesenchymal stromal cells (DP-MSCs).
- To explore DP-MSCs as a cell therapy for enhancing bone defect repair.
Main Methods:
- A critical bone defect model (5-mm) was created in the mandibles of Wistar rats.
- Rats were randomized into Simulated, Control, Evolution®, Gen-Os®, or DP-MSC treatment groups.
- Radiological, histological, and ELISA analyses were performed at 3 and 6 months post-treatment.
Main Results:
- DP-MSC treatment groups demonstrated near-complete defect restitution with uniform radiopacity and bone edge continuity.
- Histological examination revealed complete bone regeneration with well-organized, vascularized lamellar bone.
- Elevated levels of endoglin, TGF-β1, protocollagen, parathormone, and calcitonin indicated a pro-regenerative environment.
Conclusions:
- Combining DP-MSCs with biomaterials featuring suitable 3D matrices shows significant potential for bone regeneration.
- This approach represents a promising therapeutic option for critical bone defects.
- Further research into DP-MSC-based therapies for bone repair is warranted.


